Abstract
Natural two-dimensional (2D) kaolinite nanoclay has been incorporated into an emerging drug delivery system. The basal spacing of the kaolinite nanoclay was expanded from 0.72 to 4.16 nm through the intercalation of various organic guest species of different chain lengths, which can increase the efficiency in drug delivery and reduce the toxicity of doxorubicin (DOX). Original kaolinite (Kaolin) and the Kaolin intercalation compounds exhibited a high level of biocompatibility and very low toxicity towards cells of pancreatic cancer, gastric cancer, prostate cancer, breast cancer, colorectal cancer, esophageal cancer, and differentiated thyroid cancer. However, lung cancer and hepatocellular cancer cells need more strict compositional, structural, and morphological modulations for drug delivery carriers. DOX-Kaolin and the DOX-Kaolin intercalation compounds showed dramatically faster drug release in moderately acidic solution than in neutral condition, and exhibited enhanced therapeutic effects against ten model cancer cell cultures in a dose-dependent manner. The use of 2D nanoclay materials for a novel drug delivery system could feasibly pave a way towards high-performance nanotherapeutics, with superior antitumor efficacy and significantly reduced side effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dawson, J. I.; Oreffo, R. O. C. Clay: New opportunities for tissue regeneration and biomaterial design. Adv. Mater. 2013, 25, 4069–4086.
Sun, T. M.; Zhang, Y. S.; Pang, B.; Hyun, D. C.; Yang, M. X.; Xia, Y. N. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem., Int. Ed. 2014, 53, 12320–12364.
Kemp, J. A.; Shim, M. S.; Heo, C. Y.; Kwon, Y. J. “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv. Drug Deliv. Rev. 2016, 98, 3–18.
Damitz, R.; Chauhan, A. Parenteral emulsions and liposomes to treat drug overdose. Adv. Drug Deliv. Rev. 2015, 90, 12–23.
Torchilin, V. P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 2014, 13, 813–827.
Howarth, A. J.; Liu, Y. Y.; Li, P.; Li, Z. Y.; Wang, T. C.; Hupp, J. T.; Farha, O. K. Chemical, thermal and mechanical stabilities of metal-organic frameworks. Nat. Rev. Mater. 2016, 1, 15018.
Horcajada, P.; Gref, R.; Baati, T.; Allan, P. K.; Maurin, G.; Couvreur, P.; Férey, G.; Morris, R. E.; Serre, C. Metalorganic frameworks in biomedicine. Chem. Rev. 2012, 112, 1232–1268.
Kean, T.; Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev. 2010, 62, 3–11.
Park, J. H.; Saravanakumar, G.; Kim, K.; Kwon, I. C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010, 62, 28–41.
Sun, C.; Lee, J. S. H.; Zhang, M. Q. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 2008, 60, 1252–1265.
Reddy, L. H.; Arias, J. L.; Nicolas, J.; Couvreur, P. Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev. 2012, 112, 5818–5878.
Xu, C. J.; Sun, S. H. New forms of superparamagnetic nanoparticles for biomedical applications. Adv. Drug Deliv. Rev. 2013, 65, 732–743.
Assa, F.; Jafarizadeh-Malmiri, H.; Ajamein, H.; Anarjan, N.; Vaghari, H.; Sayyar, Z.; Berenjian, A. A biotechnological perspective on the application of iron oxide nanoparticles. Nano Res. 2016, 9, 2203–2225.
Hong, G. S.; Diao, S.; Antaris, A. L.; Dai, H. J. Carbon nanomaterials for biological imaging and nanomedicinal therapy. Chem. Rev. 2015, 115, 10816–10905.
Bussy, C.; Methven, L.; Kostarelos, K. Hemotoxicity of carbon nanotubes. Adv. Drug Deliv. Rev. 2013, 65, 2127–2134.
Chen, Y.; Tan, C. L.; Zhang, H.; Wang, L. Z. Twodimensional graphene analogues for biomedical applications. Chem. Soc. Rev. 2015, 44, 2681–2701.
Chen, Y.; Chen, H. R.; Shi, J. L. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv. Mater. 2013, 25, 3144–3176.
Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 2007, 17, 1225–1236.
Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C. W.; Lin, V. S. Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60, 1278–1288.
Yu, M. H.; Niu, Y. T.; Zhang, J.; Zhang, H. W.; Yang, Y. N.; Taran, E.; Jambhrunkar, S.; Gu, W. Y.; Thorn, P.; Yu, C. Z. Size-dependent gene delivery of amine-modified silica nanoparticles. Nano Res. 2016, 9, 291–305.
Luo, G. F.; Chen, W. H.; Jia, H. Z.; Sun, Y. X.; Cheng, H.; Zhuo, R. X.; Zhang, X. Z. An indicator-guided photocontrolled drug delivery system based on mesoporous silica/gold nanocomposites. Nano Res. 2015, 8, 1893–1905.
Ariga, K.; Lvov, Y. M.; Kawakami, K.; Ji, Q. M.; Hill, J. P. Layer-by-layer self-assembled shells for drug delivery. Adv. Drug Deliv. Rev. 2011, 63, 762–771.
Wang, Q.; O’Hare, D. Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. Chem. Rev. 2012, 112, 4124–4155.
Choi, S. J.; Choy, J. H. Layered double hydroxide nanoparticles as target-specific delivery carriers: Uptake mechanism and toxicity. Nanomedicine 2011, 6, 803–814.
Lvov, Y.; Wang, W. C.; Zhang, L. Q.; Fakhrullin, R. Halloysite clay nanotubes for loading and sustained release of functional compounds. Adv. Mater. 2016, 28, 1227–1250.
Vergaro, V.; Abdullayev, E.; Lvov, Y. M.; Zeitoun, A.; Cingolani, R.; Rinaldi, R.; Leporatti, S. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromolecules 2010, 11, 820–826.
Lvov, Y.; Aerov, A.; Fakhrullin, R. Clay nanotube encapsulation for functional biocomposites. Adv. Colloid Interface Sci. 2014, 207, 189–198.
Tully, J.; Yendluri, R.; Lvov, Y. Halloysite clay nanotubes for enzyme immobilization. Biomacromolecules 2016, 17, 615–621.
Niu, M. Y.; Yang, H. M.; Zhang, X. C.; Wang, Y. T.; Tang, A. D. Amine-impregnated mesoporous silica nanotube as an emerging nanocomposite for CO2 capture. ACS Appl. Mater. Interfaces 2016, 8, 17312–17320.
Li, X. Y.; Yang, Q.; Ouyang, J.; Yang, H. M.; Chang, S. Chitosan modified halloysite nanotubes as emerging porous microspheres for drug carrier. Appl. Clay Sci. 2016, 126, 306–312.
Niu, M. Y.; Li, X. Y.; Ouyang, J.; Yang, H. M. Lithium orthosilicate with halloysite as silicon source for high temperature CO2 capture. RSC Adv. 2016, 6, 44106–44112.
Jin, J.; Fu, L. J.; Yang, H. M.; Ouyang, J. Carbon hybridized halloysite nanotubes for high-performance hydrogen storage capacities. Sci. Rep. 2015, 5, 12429.
Corrales, T.; Larraza, I.; Catalina, F.; Portolés, T.; Ramírez-Santillán, C.; Matesanz, M.; Abrusci, C. In vitro biocompatibility and antimicrobial activity of poly(ɛ-caprolactone)/ montmorillonite nanocomposites. Biomacromolecules 2012, 13, 4247–4256.
Wang, Z. Y.; Zhu, W. P.; Qiu, Y.; Yi, X.; von dem Bussche, A.; Kane, A.; Gao, H. J.; Koski, K.; Hurt, R. Biological and environmental interactions of emerging twodimensional nanomaterials. Chem. Soc. Rev. 2016, 45, 1750–1780.
Durak, G. M.; Taylor, A. R.; Walker, C. E.; Probert, I.; de Vargas, C.; Audic, S.; Schroeder, D.; Brownlee, C.; Wheeler, G. L. A role for diatom-like silicon transporters in calcifying coccolithophores. Nat. Commun. 2016, 7, 10543.
Delalat, B.; Sheppard, V. C.; Ghaemi, S. R.; Rao, S. S.; Prestidge, C. A.; McPhee, G.; Rogers, M.-L.; Donoghue, J. F.; Pillay, V.; Johns, T. G. et al. Targeted drug delivery using genetically engineered diatom biosilica. Nat. Commun. 2015, 6, 8791.
Maher, S.; Alsawat, M.; Kumeria, T.; Fathalla, D.; Fetih, G.; Santos, A.; Habib, F.; Losic, D. Luminescent silicon diatom replicas: Self-reporting and degradable drug carriers with biologically derived shape for sustained delivery of therapeutics. Adv. Funct. Mater. 2015, 25, 5107–5116.
Liu, S. Y.; Yang, H. M. Composite of coal-series kaolinite and capric-lauric acid as form-stable phase-change material. Energy Technol. 2015, 3, 77–83.
Tan, D. Y.; Yuan, P.; Annabi-Bergaya, F.; Liu, D.; He, H. P. Methoxy-modified kaolinite as a novel carrier for highcapacity loading and controlled-release of the herbicide amitrole. Sci. Rep. 2015, 5, 8870.
Ghadiri, M.; Chrzanowski, W.; Rohanizadeh, R. Biomedical applications of cationic clay minerals. RSC Adv. 2015, 5, 29467–29481.
Ding, W. J.; Ouyang, J.; Yang, H. M. Synthesis and characterization of nesquehonite (MgCO3·3H2O) powders from natural talc. Powder Technol. 2016, 292, 169–175.
He, X.; Yang, H. M. Fluorescence and room temperature activity of Y2O3:(Eu3+,Au3+)/palygorskite nanocomposite. Dalton Trans. 2015, 44, 1673–1679.
Hu, P. W.; Yang, H. M. Insight into the physicochemical aspects of kaolins with different morphologies. Appl. Clay Sci. 2013, 74, 58–65.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Nos. 51225403 and 41572036), the Hunan Provincial Science and Technology Project (Nos. 2016RS2004 and 2015TP1006), the Postdoctoral Science Foundation of Central South University (No. 155219) and the China Postdoctoral Science Foundation (No. 2015M582346).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, Y., Long, M., Huang, P. et al. Intercalated 2D nanoclay for emerging drug delivery in cancer therapy. Nano Res. 10, 2633–2643 (2017). https://doi.org/10.1007/s12274-017-1466-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-017-1466-x